data_1oef_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oef _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.574 ' O ' ' HD1' ' A' ' 265' ' ' PHE . 1.7 p90 . . . . . 0 C--O 1.242 0.668 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 5.4 mm-40 -46.52 -58.48 6.65 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 122.082 0.944 . . . . 0.0 111.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 32.2 Cg_endo -82.82 -28.93 1.48 Allowed 'Trans proline' 0 N--CA 1.528 3.545 1 C-N-CA 126.557 4.838 . . . . 0.0 115.365 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.39 -28.69 69.42 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.632 -0.668 . . . . 0.0 111.344 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.91 -35.75 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.641 0.734 . . . . 0.0 111.057 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.56 -40.59 69.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.582 0.706 . . . . 0.0 111.172 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -33.67 76.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.8 0.809 . . . . 0.0 110.938 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.873 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 7.7 ttt -63.16 -27.89 69.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 0.0 111.364 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.87 -30.31 63.88 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.694 -0.629 . . . . 0.0 111.331 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -57.03 14.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.822 0.82 . . . . 0.0 110.952 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.9 -35.13 22.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.686 0.755 . . . . 0.0 111.332 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.873 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.2 t-105 -79.96 -28.45 39.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.432 0.634 . . . . 0.0 111.38 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.837 0.827 . . . . 0.0 110.968 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.18 86.55 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.32 74.47 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.952 -0.734 . . . . 0.0 111.174 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.65 -31.47 53.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.528 0.68 . . . . 0.0 111.089 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.643 0.735 . . . . 0.0 111.11 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.584 0 CA-C-O 121.434 0.635 . . . . 0.0 111.558 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.496 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.5 OUTLIER -48.65 -63.86 1.4 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.791 0.805 . . . . 0.0 111.234 172.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 266' ' ' GLU . 84.7 Cg_endo -71.52 -26.54 19.93 Favored 'Trans proline' 0 N--CA 1.53 3.649 1 C-N-CA 126.072 4.514 . . . . 0.0 115.432 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.53 -18.14 64.3 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.567 -0.708 . . . . 0.0 112.477 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 266' ' ' GLU . 1.6 p -74.7 -26.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 O-C-N 121.35 -0.844 . . . . 0.0 111.714 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.61 -36.81 70.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.674 0.749 . . . . 0.0 111.062 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -68.19 -37.17 80.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.81 0.814 . . . . 0.0 111.008 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.862 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 2.4 ttt -64.54 -27.82 69.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.396 0.617 . . . . 0.0 111.306 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -74.9 -33.02 61.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.482 0.658 . . . . 0.0 111.243 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -62.53 -47.0 85.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.731 0.776 . . . . 0.0 111.027 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -98.18 -37.54 9.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.688 0.756 . . . . 0.0 111.633 -171.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.862 ' HB3' ' O ' ' A' ' 272' ' ' MET . 3.9 t-105 -82.79 -23.53 33.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.261 0.553 . . . . 0.0 111.78 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.57 ' O ' HG11 ' A' ' 280' ' ' VAL . . . -67.1 -34.6 77.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.66 0.743 . . . . 0.0 111.064 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.85 88.93 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.67 -35.21 78.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.585 0.707 . . . . 0.0 111.386 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 277' ' ' ALA . 0.3 OUTLIER -69.89 -24.8 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.803 -0.561 . . . . 0.0 111.823 -171.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 121.537 0.684 . . . . 0.0 111.154 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.877 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 13.0 mm-40 -50.87 -58.39 10.39 Favored Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 121.361 -0.837 . . . . 0.0 110.882 172.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.877 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 41.1 Cg_endo -81.43 -15.86 9.72 Favored 'Trans proline' 0 N--CA 1.529 3.572 1 C-N-CA 126.288 4.659 . . . . 0.0 116.116 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.57 -35.84 79.8 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.373 -0.83 . . . . 0.0 111.128 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.1 -28.68 12.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.61 0.719 . . . . 0.0 111.135 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -41.67 95.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.722 0.772 . . . . 0.0 110.999 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -61.19 -35.63 77.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.681 0.753 . . . . 0.0 111.03 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.862 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 11.6 tpt -72.92 -22.17 60.78 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.944 -0.473 . . . . 0.0 112.045 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 31.45 2.16 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.652 0.739 . . . . 0.0 111.646 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.92 -43.72 2.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.592 0.71 . . . . 0.0 110.94 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -37.72 17.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.0 111.0 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.862 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.7 t-105 -79.52 -20.89 46.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.187 0.518 . . . . 0.0 111.789 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.54 88.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.64 -0.663 . . . . 0.0 111.25 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.19 -37.56 91.32 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 15.8 tp -62.69 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 121.933 -0.745 . . . . 0.0 111.406 171.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.422 HG21 ' CZ2' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -75.82 -23.51 16.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -171.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.969 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.497 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -53.93 -51.47 76.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 O-C-N 121.4 -0.812 . . . . 0.0 111.137 -178.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 47.6 Cg_exo -59.9 -46.72 18.23 Favored 'Trans proline' 0 N--CA 1.528 3.531 1 C-N-CA 126.306 4.671 . . . . 0.0 114.481 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.53 -35.33 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.638 0.732 . . . . 0.0 111.2 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.82 -37.16 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.587 0.708 . . . . 0.0 111.146 -171.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.2 -38.39 81.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.828 0.823 . . . . 0.0 110.931 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.88 -35.1 79.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.66 0.743 . . . . 0.0 111.151 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.832 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.9 OUTLIER -70.49 -26.85 63.79 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.742 -0.599 . . . . 0.0 111.776 -175.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 32.64 1.78 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.66 0.743 . . . . 0.0 111.509 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -136.4 -34.92 0.76 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.326 0.584 . . . . 0.0 111.858 172.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . 0.443 ' N ' ' HG3' ' A' ' 274' ' ' ARG . 1.5 tt0 -89.4 -37.58 14.73 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.603 0.716 . . . . 0.0 111.329 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.832 ' HB3' ' O ' ' A' ' 272' ' ' MET . 6.0 t-105 -88.28 -23.54 23.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.497 0.665 . . . . 0.0 111.382 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.2 81.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.824 0.821 . . . . 0.0 111.045 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -64.33 -35.96 92.62 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 279' ' ' LEU . 4.8 tt -65.27 -34.59 78.71 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.846 -0.796 . . . . 0.0 111.312 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.28 -33.92 58.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.605 0.717 . . . . 0.0 111.013 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 121.745 0.783 . . . . 0.0 110.893 -176.635 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' PHE . . . . . 0.881 ' HD2' HD21 ' A' ' 268' ' ' LEU . 16.8 m-85 . . . . . 0 C--O 1.24 0.597 0 CA-C-O 121.33 0.586 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.499 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -68.09 -49.91 33.18 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-O 121.794 0.807 . . . . 0.0 111.208 173.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 3.2 Cg_exo -80.02 -31.08 1.93 Allowed 'Trans proline' 0 N--CA 1.528 3.55 1 C-N-CA 126.637 4.892 . . . . 0.0 114.698 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LEU . . . . . 0.881 HD21 ' HD2' ' A' ' 265' ' ' PHE . 24.8 tp -65.48 -28.58 69.3 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.853 -0.529 . . . . 0.0 111.813 -171.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.7 t -79.16 -27.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.17 -32.8 74.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.692 0.758 . . . . 0.0 110.984 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -30.53 59.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.593 0.711 . . . . 0.0 111.211 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' MET . . . . . 0.801 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.7 -19.29 62.08 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 121.807 -0.558 . . . . 0.0 112.26 177.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -84.11 -26.33 29.03 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.464 -0.773 . . . . 0.0 111.679 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -69.27 -49.91 51.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.531 0.682 . . . . 0.0 111.374 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -37.88 11.32 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.682 -0.636 . . . . 0.0 112.279 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' TRP . . . . . 0.801 ' HB3' ' O ' ' A' ' 272' ' ' MET . 0.6 OUTLIER -84.66 -18.2 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.603 -0.686 . . . . 0.0 112.076 -171.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ALA . . . . . 0.617 ' O ' HG13 ' A' ' 280' ' ' VAL . . . -70.79 -31.81 68.69 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.536 -0.727 . . . . 0.0 111.256 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -65.69 -33.14 85.22 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.33 -29.78 53.71 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.97 -0.724 . . . . 0.0 111.817 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 277' ' ' ALA . 4.1 p -71.26 -37.3 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 121.568 -0.707 . . . . 0.0 111.516 -171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--N 1.319 -0.72 0 CA-C-O 121.849 0.833 . . . . 0.0 111.103 -173.071 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 CA-C-O 121.768 0.794 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' TRP . . . . . 0.407 ' O ' ' CG ' ' A' ' 265' ' ' PHE . 11.3 p-90 -83.42 -155.21 0.16 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.212 0.529 . . . . 0.0 110.804 -177.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.574 ' O ' ' HD1' ' A' ' 265' ' ' PHE . 1.7 p90 50.81 22.71 1.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.892 -0.505 . . . . 0.0 112.035 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 5.4 mm-40 -46.52 -58.48 6.65 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 122.082 0.944 . . . . 0.0 111.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 32.2 Cg_endo -82.82 -28.93 1.48 Allowed 'Trans proline' 0 N--CA 1.528 3.545 1 C-N-CA 126.557 4.838 . . . . 0.0 115.365 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.39 -28.69 69.42 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.632 -0.668 . . . . 0.0 111.344 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.91 -35.75 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.641 0.734 . . . . 0.0 111.057 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.56 -40.59 69.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.582 0.706 . . . . 0.0 111.172 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -33.67 76.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.8 0.809 . . . . 0.0 110.938 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.873 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 7.7 ttt -63.16 -27.89 69.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 0.0 111.364 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.87 -30.31 63.88 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.694 -0.629 . . . . 0.0 111.331 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -57.03 14.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.822 0.82 . . . . 0.0 110.952 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -84.9 -35.13 22.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.686 0.755 . . . . 0.0 111.332 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.873 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.2 t-105 -79.96 -28.45 39.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.432 0.634 . . . . 0.0 111.38 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.837 0.827 . . . . 0.0 110.968 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.18 86.55 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.32 74.47 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.952 -0.734 . . . . 0.0 111.174 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.65 -31.47 53.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.528 0.68 . . . . 0.0 111.089 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -75.75 -33.56 60.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.643 0.735 . . . . 0.0 111.11 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -67.19 -40.38 86.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.733 0.777 . . . . 0.0 110.941 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.98 -37.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.842 0.83 . . . . 0.0 111.013 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.24 -34.07 66.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.493 0.663 . . . . 0.0 111.398 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.07 -56.05 3.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.036 0.922 . . . . 0.0 111.214 -171.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.166 0 CA-C-O 121.984 0.897 . . . . 0.0 111.004 -171.655 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 121.839 0.828 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -79.33 -27.59 42.08 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.172 0.51 . . . . 0.0 111.666 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -95.4 33.3 1.61 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.48 -0.762 . . . . 0.0 111.558 -172.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.496 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.5 OUTLIER -48.65 -63.86 1.4 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.791 0.805 . . . . 0.0 111.234 172.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 266' ' ' GLU . 84.7 Cg_endo -71.52 -26.54 19.93 Favored 'Trans proline' 0 N--CA 1.53 3.649 1 C-N-CA 126.072 4.514 . . . . 0.0 115.432 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.53 -18.14 64.3 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.567 -0.708 . . . . 0.0 112.477 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 266' ' ' GLU . 1.6 p -74.7 -26.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 O-C-N 121.35 -0.844 . . . . 0.0 111.714 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.61 -36.81 70.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.674 0.749 . . . . 0.0 111.062 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -68.19 -37.17 80.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.81 0.814 . . . . 0.0 111.008 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.862 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 2.4 ttt -64.54 -27.82 69.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.396 0.617 . . . . 0.0 111.306 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -74.9 -33.02 61.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.482 0.658 . . . . 0.0 111.243 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -62.53 -47.0 85.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.731 0.776 . . . . 0.0 111.027 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -98.18 -37.54 9.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.688 0.756 . . . . 0.0 111.633 -171.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.862 ' HB3' ' O ' ' A' ' 272' ' ' MET . 3.9 t-105 -82.79 -23.53 33.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.261 0.553 . . . . 0.0 111.78 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.57 ' O ' HG11 ' A' ' 280' ' ' VAL . . . -67.1 -34.6 77.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.66 0.743 . . . . 0.0 111.064 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.85 88.93 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.67 -35.21 78.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.585 0.707 . . . . 0.0 111.386 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 277' ' ' ALA . 0.3 OUTLIER -69.89 -24.8 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.803 -0.561 . . . . 0.0 111.823 -171.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -63.7 -35.73 81.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.537 0.684 . . . . 0.0 111.154 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.15 -54.81 7.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.795 0.807 . . . . 0.0 110.976 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.32 -27.16 39.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.293 0.568 . . . . 0.0 111.797 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 280' ' ' VAL . 5.8 tt0 -90.75 26.03 2.18 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.511 -0.743 . . . . 0.0 112.26 -171.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -118.11 -28.86 5.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.775 0.798 . . . . 0.0 110.925 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.143 0 CA-C-O 121.99 0.9 . . . . 0.0 111.015 172.181 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.511 -0.525 0 CA-C-O 121.746 0.784 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 265' ' ' PHE . 8.8 p-90 -147.54 154.13 40.34 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.881 -0.512 . . . . 0.0 110.599 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER 110.42 9.97 0.0 OUTLIER 'General case' 0 C--O 1.246 0.899 0 C-N-CA 127.111 2.164 . . . . 0.0 111.939 173.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.877 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 13.0 mm-40 -50.87 -58.39 10.39 Favored Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 121.361 -0.837 . . . . 0.0 110.882 172.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.877 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 41.1 Cg_endo -81.43 -15.86 9.72 Favored 'Trans proline' 0 N--CA 1.529 3.572 1 C-N-CA 126.288 4.659 . . . . 0.0 116.116 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.425 HD11 ' HZ3' ' A' ' 264' ' ' TRP . 2.2 tt -67.57 -35.84 79.8 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.373 -0.83 . . . . 0.0 111.128 178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.1 -28.68 12.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.61 0.719 . . . . 0.0 111.135 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -41.67 95.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.722 0.772 . . . . 0.0 110.999 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -61.19 -35.63 77.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.681 0.753 . . . . 0.0 111.03 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.862 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 11.6 tpt -72.92 -22.17 60.78 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.944 -0.473 . . . . 0.0 112.045 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 31.45 2.16 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.652 0.739 . . . . 0.0 111.646 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.92 -43.72 2.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.592 0.71 . . . . 0.0 110.94 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -37.72 17.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.0 111.0 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.862 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.7 t-105 -79.52 -20.89 46.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.187 0.518 . . . . 0.0 111.789 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.54 88.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.64 -0.663 . . . . 0.0 111.25 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.19 -37.56 91.32 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.552 HD13 ' HZ3' ' A' ' 282' ' ' LYS . 15.8 tp -62.69 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 121.933 -0.745 . . . . 0.0 111.406 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.422 HG21 ' CZ2' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -75.82 -23.51 16.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -171.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -30.66 69.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . 0.552 ' HZ3' HD13 ' A' ' 279' ' ' LEU . 0.0 OUTLIER -60.2 -49.37 77.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.831 0.824 . . . . 0.0 110.888 176.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.92 -11.84 13.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -33.93 77.14 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.368 -0.833 . . . . 0.0 110.947 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -77.2 -38.92 50.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.802 0.81 . . . . 0.0 110.951 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.134 0 CA-C-O 121.995 0.902 . . . . 0.0 110.928 -176.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.511 -0.538 0 CA-C-O 121.67 0.747 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 265' ' ' PHE . 18.9 p-90 -98.27 174.12 6.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.387 0.613 . . . . 0.0 111.099 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER 99.53 -9.1 0.04 OUTLIER 'General case' 0 C--O 1.247 0.969 0 C-N-CA 125.79 1.636 . . . . 0.0 112.425 171.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.497 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -53.93 -51.47 76.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 O-C-N 121.4 -0.812 . . . . 0.0 111.137 -178.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 47.6 Cg_exo -59.9 -46.72 18.23 Favored 'Trans proline' 0 N--CA 1.528 3.531 1 C-N-CA 126.306 4.671 . . . . 0.0 114.481 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.53 -35.33 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.638 0.732 . . . . 0.0 111.2 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.82 -37.16 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.587 0.708 . . . . 0.0 111.146 -171.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.2 -38.39 81.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.828 0.823 . . . . 0.0 110.931 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.88 -35.1 79.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.66 0.743 . . . . 0.0 111.151 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.832 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.9 OUTLIER -70.49 -26.85 63.79 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.742 -0.599 . . . . 0.0 111.776 -175.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 32.64 1.78 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.66 0.743 . . . . 0.0 111.509 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.443 ' HG3' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -136.4 -34.92 0.76 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.326 0.584 . . . . 0.0 111.858 172.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.443 ' N ' ' HG3' ' A' ' 274' ' ' ARG . 1.5 tt0 -89.4 -37.58 14.73 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.603 0.716 . . . . 0.0 111.329 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.832 ' HB3' ' O ' ' A' ' 272' ' ' MET . 6.0 t-105 -88.28 -23.54 23.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.497 0.665 . . . . 0.0 111.382 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.2 81.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.824 0.821 . . . . 0.0 111.045 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -64.33 -35.96 92.62 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 279' ' ' LEU . 4.8 tt -65.27 -34.59 78.71 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.846 -0.796 . . . . 0.0 111.312 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.28 -33.92 58.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.605 0.717 . . . . 0.0 111.013 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -60.81 -40.86 94.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.745 0.783 . . . . 0.0 110.893 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.23 -41.79 76.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.739 0.78 . . . . 0.0 110.905 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.82 -24.64 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.459 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 -50.88 -40.09 55.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.79 0.805 . . . . 0.0 111.084 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -101.99 38.0 1.74 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 111.002 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.151 0 CA-C-O 121.994 0.902 . . . . 0.0 111.032 172.009 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 121.791 0.805 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -179.03 6.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.812 0.815 . . . . 0.0 111.036 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' PHE . . . . . 0.881 ' HD2' HD21 ' A' ' 268' ' ' LEU . 16.8 m-85 60.87 34.56 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.33 0.586 . . . . 0.0 111.357 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.499 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -68.09 -49.91 33.18 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-O 121.794 0.807 . . . . 0.0 111.208 173.265 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 3.2 Cg_exo -80.02 -31.08 1.93 Allowed 'Trans proline' 0 N--CA 1.528 3.55 1 C-N-CA 126.637 4.892 . . . . 0.0 114.698 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.881 HD21 ' HD2' ' A' ' 265' ' ' PHE . 24.8 tp -65.48 -28.58 69.3 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.853 -0.529 . . . . 0.0 111.813 -171.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.7 t -79.16 -27.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.17 -32.8 74.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.692 0.758 . . . . 0.0 110.984 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -30.53 59.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.593 0.711 . . . . 0.0 111.211 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' MET . . . . . 0.801 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.7 -19.29 62.08 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 121.807 -0.558 . . . . 0.0 112.26 177.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -84.11 -26.33 29.03 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.464 -0.773 . . . . 0.0 111.679 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -69.27 -49.91 51.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.531 0.682 . . . . 0.0 111.374 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -37.88 11.32 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.682 -0.636 . . . . 0.0 112.279 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . 0.801 ' HB3' ' O ' ' A' ' 272' ' ' MET . 0.6 OUTLIER -84.66 -18.2 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.603 -0.686 . . . . 0.0 112.076 -171.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ALA . . . . . 0.617 ' O ' HG13 ' A' ' 280' ' ' VAL . . . -70.79 -31.81 68.69 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.536 -0.727 . . . . 0.0 111.256 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -65.69 -33.14 85.22 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.33 -29.78 53.71 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.97 -0.724 . . . . 0.0 111.817 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 277' ' ' ALA . 4.1 p -71.26 -37.3 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 121.568 -0.707 . . . . 0.0 111.516 -171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.76 -29.63 62.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.849 0.833 . . . . 0.0 111.103 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -39.78 82.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.802 0.81 . . . . 0.0 110.973 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.47 -15.93 14.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.13 -25.46 60.85 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.446 -0.784 . . . . 0.0 111.383 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -95.69 27.77 3.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.183 0 CA-C-O 122.005 0.907 . . . . 0.0 110.993 -179.403 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.582 ' O ' ' HD1' ' A' ' 265' ' ' PHE . 1.7 p90 . . . . . 0 C--O 1.242 0.668 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 5.4 mm-40 -46.52 -58.48 6.65 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 122.082 0.944 . . . . 0.0 111.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 32.2 Cg_endo -82.82 -28.93 1.48 Allowed 'Trans proline' 0 N--CA 1.528 3.545 1 C-N-CA 126.557 4.838 . . . . 0.0 115.365 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.39 -28.69 69.42 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.632 -0.668 . . . . 0.0 111.344 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.91 -35.75 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.641 0.734 . . . . 0.0 111.057 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.56 -40.59 69.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.582 0.706 . . . . 0.0 111.172 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -33.67 76.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.8 0.809 . . . . 0.0 110.938 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.854 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 7.7 ttt -63.16 -27.89 69.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 0.0 111.364 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.87 -30.31 63.88 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.694 -0.629 . . . . 0.0 111.331 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -57.03 14.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.822 0.82 . . . . 0.0 110.952 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 276' ' ' TRP . 2.3 pt20 -84.9 -35.13 22.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.686 0.755 . . . . 0.0 111.332 -171.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.854 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.2 t-105 -79.96 -28.45 39.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.432 0.634 . . . . 0.0 111.38 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.837 0.827 . . . . 0.0 110.968 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.18 86.55 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.32 74.47 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.952 -0.734 . . . . 0.0 111.174 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.65 -31.47 53.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.528 0.68 . . . . 0.0 111.089 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.643 0.735 . . . . 0.0 111.11 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.584 0 CA-C-O 121.434 0.635 . . . . 0.0 111.558 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.5 OUTLIER -48.65 -63.86 1.4 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.791 0.805 . . . . 0.0 111.234 172.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 266' ' ' GLU . 84.7 Cg_endo -71.52 -26.54 19.93 Favored 'Trans proline' 0 N--CA 1.53 3.649 1 C-N-CA 126.072 4.514 . . . . 0.0 115.432 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.53 -18.14 64.3 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.567 -0.708 . . . . 0.0 112.477 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 266' ' ' GLU . 1.6 p -74.7 -26.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 O-C-N 121.35 -0.844 . . . . 0.0 111.714 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.61 -36.81 70.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.674 0.749 . . . . 0.0 111.062 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -68.19 -37.17 80.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.81 0.814 . . . . 0.0 111.008 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.852 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 2.4 ttt -64.54 -27.82 69.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.396 0.617 . . . . 0.0 111.306 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -74.9 -33.02 61.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.482 0.658 . . . . 0.0 111.243 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -62.53 -47.0 85.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.731 0.776 . . . . 0.0 111.027 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -98.18 -37.54 9.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.688 0.756 . . . . 0.0 111.633 -171.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.852 ' HB3' ' O ' ' A' ' 272' ' ' MET . 3.9 t-105 -82.79 -23.53 33.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.261 0.553 . . . . 0.0 111.78 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -67.1 -34.6 77.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.66 0.743 . . . . 0.0 111.064 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.85 88.93 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.67 -35.21 78.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.585 0.707 . . . . 0.0 111.386 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 277' ' ' ALA . 0.3 OUTLIER -69.89 -24.8 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.803 -0.561 . . . . 0.0 111.823 -171.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 121.537 0.684 . . . . 0.0 111.154 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.865 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 13.0 mm-40 -50.87 -58.39 10.39 Favored Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 121.361 -0.837 . . . . 0.0 110.882 172.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.865 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 41.1 Cg_endo -81.43 -15.86 9.72 Favored 'Trans proline' 0 N--CA 1.529 3.572 1 C-N-CA 126.288 4.659 . . . . 0.0 116.116 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.57 -35.84 79.8 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.373 -0.83 . . . . 0.0 111.128 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.1 -28.68 12.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.61 0.719 . . . . 0.0 111.135 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -41.67 95.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.722 0.772 . . . . 0.0 110.999 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -61.19 -35.63 77.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.681 0.753 . . . . 0.0 111.03 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.847 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 11.6 tpt -72.92 -22.17 60.78 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.944 -0.473 . . . . 0.0 112.045 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 31.45 2.16 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.652 0.739 . . . . 0.0 111.646 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.92 -43.72 2.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.592 0.71 . . . . 0.0 110.94 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -37.72 17.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.0 111.0 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.847 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.7 t-105 -79.52 -20.89 46.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.187 0.518 . . . . 0.0 111.789 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.54 88.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.64 -0.663 . . . . 0.0 111.25 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.19 -37.56 91.32 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 15.8 tp -62.69 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 121.933 -0.745 . . . . 0.0 111.406 171.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.56 HG23 ' CZ2' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -75.82 -23.51 16.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -171.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.969 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.499 ' N ' ' HD1' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -53.93 -51.47 76.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 O-C-N 121.4 -0.812 . . . . 0.0 111.137 -178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 47.6 Cg_exo -59.9 -46.72 18.23 Favored 'Trans proline' 0 N--CA 1.528 3.531 1 C-N-CA 126.306 4.671 . . . . 0.0 114.481 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.53 -35.33 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.638 0.732 . . . . 0.0 111.2 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.82 -37.16 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.587 0.708 . . . . 0.0 111.146 -171.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.2 -38.39 81.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.828 0.823 . . . . 0.0 110.931 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.88 -35.1 79.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.66 0.743 . . . . 0.0 111.151 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.822 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.9 OUTLIER -70.49 -26.85 63.79 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.742 -0.599 . . . . 0.0 111.776 -175.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 32.64 1.78 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.66 0.743 . . . . 0.0 111.509 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -136.4 -34.92 0.76 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.326 0.584 . . . . 0.0 111.858 172.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 275' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 274' ' ' ARG . 1.5 tt0 -89.4 -37.58 14.73 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.603 0.716 . . . . 0.0 111.329 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.822 ' HB3' ' O ' ' A' ' 272' ' ' MET . 6.0 t-105 -88.28 -23.54 23.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.497 0.665 . . . . 0.0 111.382 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.2 81.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.824 0.821 . . . . 0.0 111.045 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -64.33 -35.96 92.62 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 279' ' ' LEU . 4.8 tt -65.27 -34.59 78.71 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.846 -0.796 . . . . 0.0 111.312 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.28 -33.92 58.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.605 0.717 . . . . 0.0 111.013 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 121.745 0.783 . . . . 0.0 110.893 -176.635 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 265' ' ' PHE . . . . . 0.779 ' HD2' HD23 ' A' ' 268' ' ' LEU . 16.8 m-85 . . . . . 0 C--O 1.24 0.597 0 CA-C-O 121.33 0.586 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -68.09 -49.91 33.18 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-O 121.794 0.807 . . . . 0.0 111.208 173.265 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 3.2 Cg_exo -80.02 -31.08 1.93 Allowed 'Trans proline' 0 N--CA 1.528 3.55 1 C-N-CA 126.637 4.892 . . . . 0.0 114.698 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LEU . . . . . 0.779 HD23 ' HD2' ' A' ' 265' ' ' PHE . 24.8 tp -65.48 -28.58 69.3 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.853 -0.529 . . . . 0.0 111.813 -171.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.7 t -79.16 -27.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.17 -32.8 74.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.692 0.758 . . . . 0.0 110.984 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -30.53 59.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.593 0.711 . . . . 0.0 111.211 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' MET . . . . . 0.799 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.7 -19.29 62.08 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 121.807 -0.558 . . . . 0.0 112.26 177.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -84.11 -26.33 29.03 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.464 -0.773 . . . . 0.0 111.679 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -69.27 -49.91 51.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.531 0.682 . . . . 0.0 111.374 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -37.88 11.32 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.682 -0.636 . . . . 0.0 112.279 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' TRP . . . . . 0.799 ' HB3' ' O ' ' A' ' 272' ' ' MET . 0.6 OUTLIER -84.66 -18.2 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.603 -0.686 . . . . 0.0 112.076 -171.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -70.79 -31.81 68.69 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.536 -0.727 . . . . 0.0 111.256 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -65.69 -33.14 85.22 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.33 -29.78 53.71 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.97 -0.724 . . . . 0.0 111.817 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 277' ' ' ALA . 4.1 p -71.26 -37.3 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 121.568 -0.707 . . . . 0.0 111.516 -171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--N 1.319 -0.72 0 CA-C-O 121.849 0.833 . . . . 0.0 111.103 -173.071 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 CA-C-O 121.768 0.794 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' TRP . . . . . 0.407 ' O ' ' CG ' ' A' ' 265' ' ' PHE . 11.3 p-90 -83.42 -155.21 0.16 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.212 0.529 . . . . 0.0 110.804 -177.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.582 ' O ' ' HD1' ' A' ' 265' ' ' PHE . 1.7 p90 50.81 22.71 1.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.892 -0.505 . . . . 0.0 112.035 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 5.4 mm-40 -46.52 -58.48 6.65 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 122.082 0.944 . . . . 0.0 111.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 32.2 Cg_endo -82.82 -28.93 1.48 Allowed 'Trans proline' 0 N--CA 1.528 3.545 1 C-N-CA 126.557 4.838 . . . . 0.0 115.365 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.39 -28.69 69.42 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.632 -0.668 . . . . 0.0 111.344 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.91 -35.75 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.641 0.734 . . . . 0.0 111.057 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.56 -40.59 69.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.582 0.706 . . . . 0.0 111.172 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -33.67 76.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.8 0.809 . . . . 0.0 110.938 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.854 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 7.7 ttt -63.16 -27.89 69.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 0.0 111.364 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.87 -30.31 63.88 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.694 -0.629 . . . . 0.0 111.331 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -57.03 14.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.822 0.82 . . . . 0.0 110.952 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 276' ' ' TRP . 2.3 pt20 -84.9 -35.13 22.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.686 0.755 . . . . 0.0 111.332 -171.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.854 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.2 t-105 -79.96 -28.45 39.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.432 0.634 . . . . 0.0 111.38 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.837 0.827 . . . . 0.0 110.968 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.18 86.55 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.32 74.47 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.952 -0.734 . . . . 0.0 111.174 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.65 -31.47 53.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.528 0.68 . . . . 0.0 111.089 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -75.75 -33.56 60.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.643 0.735 . . . . 0.0 111.11 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -67.19 -40.38 86.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.733 0.777 . . . . 0.0 110.941 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.98 -37.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.842 0.83 . . . . 0.0 111.013 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.24 -34.07 66.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.493 0.663 . . . . 0.0 111.398 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.07 -56.05 3.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.036 0.922 . . . . 0.0 111.214 -171.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.166 0 CA-C-O 121.984 0.897 . . . . 0.0 111.004 -171.655 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 121.839 0.828 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 264' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -79.33 -27.59 42.08 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.172 0.51 . . . . 0.0 111.666 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -95.4 33.3 1.61 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.48 -0.762 . . . . 0.0 111.558 -172.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.5 OUTLIER -48.65 -63.86 1.4 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.791 0.805 . . . . 0.0 111.234 172.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 266' ' ' GLU . 84.7 Cg_endo -71.52 -26.54 19.93 Favored 'Trans proline' 0 N--CA 1.53 3.649 1 C-N-CA 126.072 4.514 . . . . 0.0 115.432 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.53 -18.14 64.3 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.567 -0.708 . . . . 0.0 112.477 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 266' ' ' GLU . 1.6 p -74.7 -26.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 O-C-N 121.35 -0.844 . . . . 0.0 111.714 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.61 -36.81 70.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.674 0.749 . . . . 0.0 111.062 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -68.19 -37.17 80.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.81 0.814 . . . . 0.0 111.008 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.852 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 2.4 ttt -64.54 -27.82 69.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.396 0.617 . . . . 0.0 111.306 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -74.9 -33.02 61.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.482 0.658 . . . . 0.0 111.243 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -62.53 -47.0 85.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.731 0.776 . . . . 0.0 111.027 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -98.18 -37.54 9.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.688 0.756 . . . . 0.0 111.633 -171.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.852 ' HB3' ' O ' ' A' ' 272' ' ' MET . 3.9 t-105 -82.79 -23.53 33.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.261 0.553 . . . . 0.0 111.78 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -67.1 -34.6 77.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.66 0.743 . . . . 0.0 111.064 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.85 88.93 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.67 -35.21 78.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.585 0.707 . . . . 0.0 111.386 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 277' ' ' ALA . 0.3 OUTLIER -69.89 -24.8 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.803 -0.561 . . . . 0.0 111.823 -171.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -63.7 -35.73 81.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.537 0.684 . . . . 0.0 111.154 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.15 -54.81 7.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.795 0.807 . . . . 0.0 110.976 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.32 -27.16 39.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.293 0.568 . . . . 0.0 111.797 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -90.75 26.03 2.18 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.511 -0.743 . . . . 0.0 112.26 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -118.11 -28.86 5.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.775 0.798 . . . . 0.0 110.925 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.143 0 CA-C-O 121.99 0.9 . . . . 0.0 111.015 172.181 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.511 -0.525 0 CA-C-O 121.746 0.784 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 264' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 265' ' ' PHE . 8.8 p-90 -147.54 154.13 40.34 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.881 -0.512 . . . . 0.0 110.599 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER 110.42 9.97 0.0 OUTLIER 'General case' 0 C--O 1.246 0.899 0 C-N-CA 127.111 2.164 . . . . 0.0 111.939 173.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.865 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 13.0 mm-40 -50.87 -58.39 10.39 Favored Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 121.361 -0.837 . . . . 0.0 110.882 172.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.865 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 41.1 Cg_endo -81.43 -15.86 9.72 Favored 'Trans proline' 0 N--CA 1.529 3.572 1 C-N-CA 126.288 4.659 . . . . 0.0 116.116 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.57 -35.84 79.8 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.373 -0.83 . . . . 0.0 111.128 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.1 -28.68 12.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.61 0.719 . . . . 0.0 111.135 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -41.67 95.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.722 0.772 . . . . 0.0 110.999 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -61.19 -35.63 77.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.681 0.753 . . . . 0.0 111.03 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.847 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 11.6 tpt -72.92 -22.17 60.78 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.944 -0.473 . . . . 0.0 112.045 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 31.45 2.16 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.652 0.739 . . . . 0.0 111.646 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.92 -43.72 2.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.592 0.71 . . . . 0.0 110.94 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -37.72 17.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.0 111.0 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.847 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.7 t-105 -79.52 -20.89 46.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.187 0.518 . . . . 0.0 111.789 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.54 88.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.64 -0.663 . . . . 0.0 111.25 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.19 -37.56 91.32 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 15.8 tp -62.69 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 121.933 -0.745 . . . . 0.0 111.406 171.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.56 HG23 ' CZ2' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -75.82 -23.51 16.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -171.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -30.66 69.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -49.37 77.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.831 0.824 . . . . 0.0 110.888 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.92 -11.84 13.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -33.93 77.14 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.368 -0.833 . . . . 0.0 110.947 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -77.2 -38.92 50.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.802 0.81 . . . . 0.0 110.951 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.134 0 CA-C-O 121.995 0.902 . . . . 0.0 110.928 -176.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.511 -0.538 0 CA-C-O 121.67 0.747 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 264' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 265' ' ' PHE . 18.9 p-90 -98.27 174.12 6.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.387 0.613 . . . . 0.0 111.099 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER 99.53 -9.1 0.04 OUTLIER 'General case' 0 C--O 1.247 0.969 0 C-N-CA 125.79 1.636 . . . . 0.0 112.425 171.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.499 ' N ' ' HD1' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -53.93 -51.47 76.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 O-C-N 121.4 -0.812 . . . . 0.0 111.137 -178.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 47.6 Cg_exo -59.9 -46.72 18.23 Favored 'Trans proline' 0 N--CA 1.528 3.531 1 C-N-CA 126.306 4.671 . . . . 0.0 114.481 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.53 -35.33 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.638 0.732 . . . . 0.0 111.2 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.82 -37.16 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.587 0.708 . . . . 0.0 111.146 -171.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.2 -38.39 81.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.828 0.823 . . . . 0.0 110.931 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.88 -35.1 79.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.66 0.743 . . . . 0.0 111.151 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.822 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.9 OUTLIER -70.49 -26.85 63.79 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.742 -0.599 . . . . 0.0 111.776 -175.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 32.64 1.78 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.66 0.743 . . . . 0.0 111.509 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -136.4 -34.92 0.76 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.326 0.584 . . . . 0.0 111.858 172.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 274' ' ' ARG . 1.5 tt0 -89.4 -37.58 14.73 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.603 0.716 . . . . 0.0 111.329 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.822 ' HB3' ' O ' ' A' ' 272' ' ' MET . 6.0 t-105 -88.28 -23.54 23.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.497 0.665 . . . . 0.0 111.382 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.2 81.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.824 0.821 . . . . 0.0 111.045 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -64.33 -35.96 92.62 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 279' ' ' LEU . 4.8 tt -65.27 -34.59 78.71 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.846 -0.796 . . . . 0.0 111.312 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.28 -33.92 58.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.605 0.717 . . . . 0.0 111.013 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -60.81 -40.86 94.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.745 0.783 . . . . 0.0 110.893 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.23 -41.79 76.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.739 0.78 . . . . 0.0 110.905 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.82 -24.64 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.459 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 -50.88 -40.09 55.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.79 0.805 . . . . 0.0 111.084 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -101.99 38.0 1.74 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 111.002 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.151 0 CA-C-O 121.994 0.902 . . . . 0.0 111.032 172.009 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 121.791 0.805 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 264' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -179.03 6.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.812 0.815 . . . . 0.0 111.036 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' PHE . . . . . 0.779 ' HD2' HD23 ' A' ' 268' ' ' LEU . 16.8 m-85 60.87 34.56 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.33 0.586 . . . . 0.0 111.357 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -68.09 -49.91 33.18 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-O 121.794 0.807 . . . . 0.0 111.208 173.265 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 3.2 Cg_exo -80.02 -31.08 1.93 Allowed 'Trans proline' 0 N--CA 1.528 3.55 1 C-N-CA 126.637 4.892 . . . . 0.0 114.698 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.779 HD23 ' HD2' ' A' ' 265' ' ' PHE . 24.8 tp -65.48 -28.58 69.3 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.853 -0.529 . . . . 0.0 111.813 -171.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.7 t -79.16 -27.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.17 -32.8 74.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.692 0.758 . . . . 0.0 110.984 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -30.53 59.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.593 0.711 . . . . 0.0 111.211 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' MET . . . . . 0.799 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.7 -19.29 62.08 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 121.807 -0.558 . . . . 0.0 112.26 177.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -84.11 -26.33 29.03 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.464 -0.773 . . . . 0.0 111.679 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -69.27 -49.91 51.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.531 0.682 . . . . 0.0 111.374 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -37.88 11.32 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.682 -0.636 . . . . 0.0 112.279 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.799 ' HB3' ' O ' ' A' ' 272' ' ' MET . 0.6 OUTLIER -84.66 -18.2 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.603 -0.686 . . . . 0.0 112.076 -171.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -70.79 -31.81 68.69 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.536 -0.727 . . . . 0.0 111.256 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -65.69 -33.14 85.22 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.33 -29.78 53.71 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.97 -0.724 . . . . 0.0 111.817 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 277' ' ' ALA . 4.1 p -71.26 -37.3 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 121.568 -0.707 . . . . 0.0 111.516 -171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.76 -29.63 62.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.849 0.833 . . . . 0.0 111.103 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -39.78 82.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.802 0.81 . . . . 0.0 110.973 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.47 -15.93 14.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.13 -25.46 60.85 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.446 -0.784 . . . . 0.0 111.383 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -95.69 27.77 3.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.183 0 CA-C-O 122.005 0.907 . . . . 0.0 110.993 -179.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.582 ' O ' ' HD1' ' A' ' 265' ' ' PHE . 1.7 p90 . . . . . 0 C--O 1.242 0.668 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 5.4 mm-40 -46.52 -58.48 6.65 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 122.082 0.944 . . . . 0.0 111.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 32.2 Cg_endo -82.82 -28.93 1.48 Allowed 'Trans proline' 0 N--CA 1.528 3.545 1 C-N-CA 126.557 4.838 . . . . 0.0 115.365 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.39 -28.69 69.42 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.632 -0.668 . . . . 0.0 111.344 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.91 -35.75 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.641 0.734 . . . . 0.0 111.057 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.56 -40.59 69.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.582 0.706 . . . . 0.0 111.172 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -33.67 76.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.8 0.809 . . . . 0.0 110.938 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.854 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 7.7 ttt -63.16 -27.89 69.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 0.0 111.364 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.87 -30.31 63.88 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.694 -0.629 . . . . 0.0 111.331 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -57.03 14.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.822 0.82 . . . . 0.0 110.952 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 276' ' ' TRP . 2.3 pt20 -84.9 -35.13 22.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.686 0.755 . . . . 0.0 111.332 -171.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.854 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.2 t-105 -79.96 -28.45 39.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.432 0.634 . . . . 0.0 111.38 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.837 0.827 . . . . 0.0 110.968 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.18 86.55 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.32 74.47 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.952 -0.734 . . . . 0.0 111.174 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.65 -31.47 53.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.528 0.68 . . . . 0.0 111.089 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--N 1.32 -0.717 0 CA-C-O 121.643 0.735 . . . . 0.0 111.11 -179.436 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.584 0 CA-C-O 121.434 0.635 . . . . 0.0 111.558 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.5 OUTLIER -48.65 -63.86 1.4 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.791 0.805 . . . . 0.0 111.234 172.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 266' ' ' GLU . 84.7 Cg_endo -71.52 -26.54 19.93 Favored 'Trans proline' 0 N--CA 1.53 3.649 1 C-N-CA 126.072 4.514 . . . . 0.0 115.432 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.53 -18.14 64.3 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.567 -0.708 . . . . 0.0 112.477 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 266' ' ' GLU . 1.6 p -74.7 -26.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 O-C-N 121.35 -0.844 . . . . 0.0 111.714 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.61 -36.81 70.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.674 0.749 . . . . 0.0 111.062 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -68.19 -37.17 80.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.81 0.814 . . . . 0.0 111.008 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.852 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 2.4 ttt -64.54 -27.82 69.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.396 0.617 . . . . 0.0 111.306 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -74.9 -33.02 61.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.482 0.658 . . . . 0.0 111.243 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -62.53 -47.0 85.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.731 0.776 . . . . 0.0 111.027 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -98.18 -37.54 9.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.688 0.756 . . . . 0.0 111.633 -171.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.852 ' HB3' ' O ' ' A' ' 272' ' ' MET . 3.9 t-105 -82.79 -23.53 33.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.261 0.553 . . . . 0.0 111.78 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -67.1 -34.6 77.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.66 0.743 . . . . 0.0 111.064 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.85 88.93 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.67 -35.21 78.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.585 0.707 . . . . 0.0 111.386 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 277' ' ' ALA . 0.3 OUTLIER -69.89 -24.8 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.803 -0.561 . . . . 0.0 111.823 -171.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--N 1.319 -0.733 0 CA-C-O 121.537 0.684 . . . . 0.0 111.154 179.232 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.865 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 13.0 mm-40 -50.87 -58.39 10.39 Favored Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 121.361 -0.837 . . . . 0.0 110.882 172.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.865 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 41.1 Cg_endo -81.43 -15.86 9.72 Favored 'Trans proline' 0 N--CA 1.529 3.572 1 C-N-CA 126.288 4.659 . . . . 0.0 116.116 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.57 -35.84 79.8 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.373 -0.83 . . . . 0.0 111.128 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.1 -28.68 12.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.61 0.719 . . . . 0.0 111.135 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -41.67 95.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.722 0.772 . . . . 0.0 110.999 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -61.19 -35.63 77.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.681 0.753 . . . . 0.0 111.03 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.847 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 11.6 tpt -72.92 -22.17 60.78 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.944 -0.473 . . . . 0.0 112.045 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 31.45 2.16 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.652 0.739 . . . . 0.0 111.646 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.92 -43.72 2.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.592 0.71 . . . . 0.0 110.94 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -37.72 17.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.0 111.0 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.847 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.7 t-105 -79.52 -20.89 46.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.187 0.518 . . . . 0.0 111.789 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.54 88.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.64 -0.663 . . . . 0.0 111.25 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.19 -37.56 91.32 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 15.8 tp -62.69 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 121.933 -0.745 . . . . 0.0 111.406 171.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.56 HG23 ' CZ2' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -75.82 -23.51 16.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -171.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.712 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 172.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.969 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.499 ' N ' ' HD1' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -53.93 -51.47 76.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 O-C-N 121.4 -0.812 . . . . 0.0 111.137 -178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 47.6 Cg_exo -59.9 -46.72 18.23 Favored 'Trans proline' 0 N--CA 1.528 3.531 1 C-N-CA 126.306 4.671 . . . . 0.0 114.481 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.53 -35.33 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.638 0.732 . . . . 0.0 111.2 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.82 -37.16 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.587 0.708 . . . . 0.0 111.146 -171.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.2 -38.39 81.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.828 0.823 . . . . 0.0 110.931 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.88 -35.1 79.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.66 0.743 . . . . 0.0 111.151 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.822 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.9 OUTLIER -70.49 -26.85 63.79 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.742 -0.599 . . . . 0.0 111.776 -175.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 32.64 1.78 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.66 0.743 . . . . 0.0 111.509 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -136.4 -34.92 0.76 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.326 0.584 . . . . 0.0 111.858 172.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 274' ' ' ARG . 1.5 tt0 -89.4 -37.58 14.73 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.603 0.716 . . . . 0.0 111.329 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.822 ' HB3' ' O ' ' A' ' 272' ' ' MET . 6.0 t-105 -88.28 -23.54 23.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.497 0.665 . . . . 0.0 111.382 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.2 81.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.824 0.821 . . . . 0.0 111.045 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -64.33 -35.96 92.62 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 279' ' ' LEU . 4.8 tt -65.27 -34.59 78.71 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.846 -0.796 . . . . 0.0 111.312 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.28 -33.92 58.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.605 0.717 . . . . 0.0 111.013 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 121.745 0.783 . . . . 0.0 110.893 -176.635 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' PHE . . . . . 0.779 ' HD2' HD23 ' A' ' 268' ' ' LEU . 16.8 m-85 . . . . . 0 C--O 1.24 0.597 0 CA-C-O 121.33 0.586 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -68.09 -49.91 33.18 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-O 121.794 0.807 . . . . 0.0 111.208 173.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 3.2 Cg_exo -80.02 -31.08 1.93 Allowed 'Trans proline' 0 N--CA 1.528 3.55 1 C-N-CA 126.637 4.892 . . . . 0.0 114.698 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LEU . . . . . 0.779 HD23 ' HD2' ' A' ' 265' ' ' PHE . 24.8 tp -65.48 -28.58 69.3 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.853 -0.529 . . . . 0.0 111.813 -171.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.7 t -79.16 -27.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.17 -32.8 74.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.692 0.758 . . . . 0.0 110.984 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -30.53 59.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.593 0.711 . . . . 0.0 111.211 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' MET . . . . . 0.799 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.7 -19.29 62.08 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 121.807 -0.558 . . . . 0.0 112.26 177.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -84.11 -26.33 29.03 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.464 -0.773 . . . . 0.0 111.679 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -69.27 -49.91 51.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.531 0.682 . . . . 0.0 111.374 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -37.88 11.32 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.682 -0.636 . . . . 0.0 112.279 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' TRP . . . . . 0.799 ' HB3' ' O ' ' A' ' 272' ' ' MET . 0.6 OUTLIER -84.66 -18.2 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.603 -0.686 . . . . 0.0 112.076 -171.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -70.79 -31.81 68.69 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.536 -0.727 . . . . 0.0 111.256 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -65.69 -33.14 85.22 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.33 -29.78 53.71 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.97 -0.724 . . . . 0.0 111.817 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 277' ' ' ALA . 4.1 p -71.26 -37.3 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 121.568 -0.707 . . . . 0.0 111.516 -171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--N 1.319 -0.72 0 CA-C-O 121.849 0.833 . . . . 0.0 111.103 -173.071 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 CA-C-O 121.768 0.794 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' TRP . . . . . 0.407 ' O ' ' CG ' ' A' ' 265' ' ' PHE . 11.3 p-90 -83.42 -155.21 0.16 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.212 0.529 . . . . 0.0 110.804 -177.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.582 ' O ' ' HD1' ' A' ' 265' ' ' PHE . 1.7 p90 50.81 22.71 1.2 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.892 -0.505 . . . . 0.0 112.035 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.591 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 5.4 mm-40 -46.52 -58.48 6.65 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 122.082 0.944 . . . . 0.0 111.442 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 32.2 Cg_endo -82.82 -28.93 1.48 Allowed 'Trans proline' 0 N--CA 1.528 3.545 1 C-N-CA 126.557 4.838 . . . . 0.0 115.365 -176.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.39 -28.69 69.42 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 121.632 -0.668 . . . . 0.0 111.344 177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.91 -35.75 74.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.641 0.734 . . . . 0.0 111.057 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -71.56 -40.59 69.88 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.582 0.706 . . . . 0.0 111.172 -172.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -33.67 76.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.8 0.809 . . . . 0.0 110.938 173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.854 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 7.7 ttt -63.16 -27.89 69.68 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.383 0.611 . . . . 0.0 111.364 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.87 -30.31 63.88 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.694 -0.629 . . . . 0.0 111.331 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -57.03 14.39 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.822 0.82 . . . . 0.0 110.952 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 276' ' ' TRP . 2.3 pt20 -84.9 -35.13 22.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.686 0.755 . . . . 0.0 111.332 -171.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.854 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.2 t-105 -79.96 -28.45 39.62 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.432 0.634 . . . . 0.0 111.38 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.29 -31.85 71.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.837 0.827 . . . . 0.0 110.968 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.18 86.55 Favored Glycine 0 C--O 1.238 0.347 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.32 -34.32 74.47 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.952 -0.734 . . . . 0.0 111.174 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.65 -31.47 53.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.528 0.68 . . . . 0.0 111.089 -174.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -75.75 -33.56 60.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.643 0.735 . . . . 0.0 111.11 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -67.19 -40.38 86.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.733 0.777 . . . . 0.0 110.941 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.98 -37.45 17.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.842 0.83 . . . . 0.0 111.013 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -56.24 -34.07 66.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.493 0.663 . . . . 0.0 111.398 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -87.07 -56.05 3.55 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.036 0.922 . . . . 0.0 111.214 -171.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.166 0 CA-C-O 121.984 0.897 . . . . 0.0 111.004 -171.655 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 CA--C 1.511 -0.54 0 CA-C-O 121.839 0.828 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' TRP . . . . . . . . . . . . . 60.7 p-90 -79.33 -27.59 42.08 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.172 0.51 . . . . 0.0 111.666 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -95.4 33.3 1.61 Allowed 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.48 -0.762 . . . . 0.0 111.558 -172.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.54 ' HB3' ' HD3' ' A' ' 267' ' ' PRO . 0.5 OUTLIER -48.65 -63.86 1.4 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.791 0.805 . . . . 0.0 111.234 172.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 266' ' ' GLU . 84.7 Cg_endo -71.52 -26.54 19.93 Favored 'Trans proline' 0 N--CA 1.53 3.649 1 C-N-CA 126.072 4.514 . . . . 0.0 115.432 -176.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.53 -18.14 64.3 Favored 'General case' 0 C--O 1.245 0.849 0 O-C-N 121.567 -0.708 . . . . 0.0 112.477 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 266' ' ' GLU . 1.6 p -74.7 -26.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 O-C-N 121.35 -0.844 . . . . 0.0 111.714 -174.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.61 -36.81 70.93 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.674 0.749 . . . . 0.0 111.062 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -68.19 -37.17 80.65 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.81 0.814 . . . . 0.0 111.008 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.852 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 2.4 ttt -64.54 -27.82 69.22 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.396 0.617 . . . . 0.0 111.306 174.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -74.9 -33.02 61.97 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.482 0.658 . . . . 0.0 111.243 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.5 mtt85 -62.53 -47.0 85.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.731 0.776 . . . . 0.0 111.027 -174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -98.18 -37.54 9.66 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.688 0.756 . . . . 0.0 111.633 -171.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.852 ' HB3' ' O ' ' A' ' 272' ' ' MET . 3.9 t-105 -82.79 -23.53 33.81 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.261 0.553 . . . . 0.0 111.78 -171.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.661 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -67.1 -34.6 77.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.66 0.743 . . . . 0.0 111.064 173.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.57 -36.85 88.93 Favored Glycine 0 C--N 1.321 -0.293 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.67 -35.21 78.93 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.585 0.707 . . . . 0.0 111.386 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 277' ' ' ALA . 0.3 OUTLIER -69.89 -24.8 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 O-C-N 121.803 -0.561 . . . . 0.0 111.823 -171.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -63.7 -35.73 81.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.537 0.684 . . . . 0.0 111.154 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -73.15 -54.81 7.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.795 0.807 . . . . 0.0 110.976 -177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.32 -27.16 39.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-O 121.293 0.568 . . . . 0.0 111.797 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -90.75 26.03 2.18 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.511 -0.743 . . . . 0.0 112.26 -171.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -118.11 -28.86 5.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.775 0.798 . . . . 0.0 110.925 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.143 0 CA-C-O 121.99 0.9 . . . . 0.0 111.015 172.181 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 CA--C 1.511 -0.525 0 CA-C-O 121.746 0.784 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' TRP . . . . . 0.498 ' O ' ' CB ' ' A' ' 265' ' ' PHE . 8.8 p-90 -147.54 154.13 40.34 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.881 -0.512 . . . . 0.0 110.599 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.56 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER 110.42 9.97 0.0 OUTLIER 'General case' 0 C--O 1.246 0.899 0 C-N-CA 127.111 2.164 . . . . 0.0 111.939 173.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.865 ' HB2' ' HD3' ' A' ' 267' ' ' PRO . 13.0 mm-40 -50.87 -58.39 10.39 Favored Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 121.361 -0.837 . . . . 0.0 110.882 172.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.865 ' HD3' ' HB2' ' A' ' 266' ' ' GLU . 41.1 Cg_endo -81.43 -15.86 9.72 Favored 'Trans proline' 0 N--CA 1.529 3.572 1 C-N-CA 126.288 4.659 . . . . 0.0 116.116 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.57 -35.84 79.8 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.373 -0.83 . . . . 0.0 111.128 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.1 -28.68 12.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.61 0.719 . . . . 0.0 111.135 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.74 -41.67 95.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.722 0.772 . . . . 0.0 110.999 175.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -61.19 -35.63 77.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.681 0.753 . . . . 0.0 111.03 172.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.847 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 11.6 tpt -72.92 -22.17 60.78 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.944 -0.473 . . . . 0.0 112.045 -173.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.1 31.45 2.16 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.652 0.739 . . . . 0.0 111.646 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.92 -43.72 2.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.592 0.71 . . . . 0.0 110.94 171.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.8 -37.72 17.54 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.828 0.823 . . . . 0.0 111.0 177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.847 ' HB3' ' O ' ' A' ' 272' ' ' MET . 1.7 t-105 -79.52 -20.89 46.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.187 0.518 . . . . 0.0 111.789 -178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -61.65 -38.54 88.11 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.64 -0.663 . . . . 0.0 111.25 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -67.19 -37.56 91.32 Favored Glycine 0 N--CA 1.461 0.358 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 15.8 tp -62.69 -33.52 75.24 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 121.933 -0.745 . . . . 0.0 111.406 171.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.56 HG23 ' CZ2' ' A' ' 276' ' ' TRP . 0.4 OUTLIER -75.82 -23.51 16.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -171.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -30.66 69.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.661 0.743 . . . . 0.0 111.148 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -49.37 77.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.831 0.824 . . . . 0.0 110.888 176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.92 -11.84 13.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -33.93 77.14 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.368 -0.833 . . . . 0.0 110.947 175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -77.2 -38.92 50.45 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.802 0.81 . . . . 0.0 110.951 176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.134 0 CA-C-O 121.995 0.902 . . . . 0.0 110.928 -176.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.1 p . . . . . 0 CA--C 1.511 -0.538 0 CA-C-O 121.67 0.747 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' TRP . . . . . 0.46 ' O ' ' CB ' ' A' ' 265' ' ' PHE . 18.9 p-90 -98.27 174.12 6.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.387 0.613 . . . . 0.0 111.099 174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.549 ' CD1' ' C ' ' A' ' 265' ' ' PHE . 0.0 OUTLIER 99.53 -9.1 0.04 OUTLIER 'General case' 0 C--O 1.247 0.969 0 C-N-CA 125.79 1.636 . . . . 0.0 112.425 171.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.499 ' N ' ' HD1' ' A' ' 265' ' ' PHE . 0.0 OUTLIER -53.93 -51.47 76.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 O-C-N 121.4 -0.812 . . . . 0.0 111.137 -178.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 47.6 Cg_exo -59.9 -46.72 18.23 Favored 'Trans proline' 0 N--CA 1.528 3.531 1 C-N-CA 126.306 4.671 . . . . 0.0 114.481 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.53 -35.33 77.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.638 0.732 . . . . 0.0 111.2 -173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.82 -37.16 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.587 0.708 . . . . 0.0 111.146 -171.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -68.2 -38.39 81.93 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.828 0.823 . . . . 0.0 110.931 -171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -63.88 -35.1 79.54 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.66 0.743 . . . . 0.0 111.151 171.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.822 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.9 OUTLIER -70.49 -26.85 63.79 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.742 -0.599 . . . . 0.0 111.776 -175.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.66 32.64 1.78 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.66 0.743 . . . . 0.0 111.509 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 275' ' ' GLN . 0.0 OUTLIER -136.4 -34.92 0.76 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.326 0.584 . . . . 0.0 111.858 172.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 274' ' ' ARG . 1.5 tt0 -89.4 -37.58 14.73 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.603 0.716 . . . . 0.0 111.329 172.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.822 ' HB3' ' O ' ' A' ' 272' ' ' MET . 6.0 t-105 -88.28 -23.54 23.45 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.497 0.665 . . . . 0.0 111.382 -175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . . . . . . . . . . . -68.3 -40.2 81.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.824 0.821 . . . . 0.0 111.045 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -64.33 -35.96 92.62 Favored Glycine 0 C--O 1.238 0.398 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 173.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.537 ' O ' HD23 ' A' ' 279' ' ' LEU . 4.8 tt -65.27 -34.59 78.71 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.846 -0.796 . . . . 0.0 111.312 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.28 -33.92 58.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.605 0.717 . . . . 0.0 111.013 -172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -60.81 -40.86 94.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.745 0.783 . . . . 0.0 110.893 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -56.23 -41.79 76.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.739 0.78 . . . . 0.0 110.905 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 2.1 t -76.82 -24.64 15.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.455 0.645 . . . . 0.0 111.459 -172.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 -50.88 -40.09 55.64 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.79 0.805 . . . . 0.0 111.084 174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -101.99 38.0 1.74 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.766 0.793 . . . . 0.0 111.002 -171.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.151 0 CA-C-O 121.994 0.902 . . . . 0.0 111.032 172.009 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.512 -0.508 0 CA-C-O 121.791 0.805 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -79.37 -179.03 6.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.812 0.815 . . . . 0.0 111.036 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' PHE . . . . . 0.779 ' HD2' HD23 ' A' ' 268' ' ' LEU . 16.8 m-85 60.87 34.56 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.33 0.586 . . . . 0.0 111.357 -175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.472 ' CB ' ' HD3' ' A' ' 267' ' ' PRO . 0.0 OUTLIER -68.09 -49.91 33.18 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-O 121.794 0.807 . . . . 0.0 111.208 173.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' A' ' 266' ' ' GLU . 3.2 Cg_exo -80.02 -31.08 1.93 Allowed 'Trans proline' 0 N--CA 1.528 3.55 1 C-N-CA 126.637 4.892 . . . . 0.0 114.698 176.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.779 HD23 ' HD2' ' A' ' 265' ' ' PHE . 24.8 tp -65.48 -28.58 69.3 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 121.853 -0.529 . . . . 0.0 111.813 -171.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.7 t -79.16 -27.8 13.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.639 -0.663 . . . . 0.0 111.306 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -66.17 -32.8 74.46 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.692 0.758 . . . . 0.0 110.984 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 -30.53 59.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.593 0.711 . . . . 0.0 111.211 173.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' MET . . . . . 0.799 ' O ' ' HB3' ' A' ' 276' ' ' TRP . 0.0 OUTLIER -71.7 -19.29 62.08 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 121.807 -0.558 . . . . 0.0 112.26 177.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -84.11 -26.33 29.03 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.464 -0.773 . . . . 0.0 111.679 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -69.27 -49.91 51.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.531 0.682 . . . . 0.0 111.374 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -37.88 11.32 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 121.682 -0.636 . . . . 0.0 112.279 -170.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.799 ' HB3' ' O ' ' A' ' 272' ' ' MET . 0.6 OUTLIER -84.66 -18.2 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.603 -0.686 . . . . 0.0 112.076 -171.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 280' ' ' VAL . . . -70.79 -31.81 68.69 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.536 -0.727 . . . . 0.0 111.256 172.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -65.69 -33.14 85.22 Favored Glycine 0 C--O 1.237 0.329 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 171.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 9.1 tp -77.33 -29.78 53.71 Favored 'General case' 0 C--O 1.242 0.709 0 O-C-N 121.97 -0.724 . . . . 0.0 111.817 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 277' ' ' ALA . 4.1 p -71.26 -37.3 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 O-C-N 121.568 -0.707 . . . . 0.0 111.516 -171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -73.76 -29.63 62.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.849 0.833 . . . . 0.0 111.103 -173.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -39.78 82.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.802 0.81 . . . . 0.0 110.973 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' VAL . . . . . . . . . . . . . 11.3 t -77.47 -15.93 14.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -73.13 -25.46 60.85 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 121.446 -0.784 . . . . 0.0 111.383 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -95.69 27.77 3.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.27 2.183 0 CA-C-O 122.005 0.907 . . . . 0.0 110.993 -179.403 . . . . . . . . 0 0 . 1 stop_ save_